Silvana Morello

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Allergic Rhinitis

Top Venues

Journal for immunotherapy of cancer

Journal of translational medicine

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

This page only lists publications with an associated author ORCID identifier.

Publications

Carla Cicala, Silvana Morello
Signaling Pathways in Inflammation and Its Resolution: New Insights and Therapeutic Challenges. International journal of molecular sciences 24 (13) (2023)
Silvana Morello, Carla Cicala
Ecto-5'-nucleotidase (CD73): an emerging role as prognostic factor in allergic sensitization. Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2023)
Elisabetta Caiazzo, Ida Cerqua, Roberta Turiello, Maria Antonietta Riemma, Giacomo De Palma, Armando Ialenti, Fiorentina Roviezzo, Silvana Morello, Carla Cicala
Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge. Biomolecules 12 (5) (2022)
Roberta Turiello, Mariaelena Capone, Elva Morretta, Maria Chiara Monti, Gabriele Madonna, Rosa Azzaro, Pasquale Del Gaudio, Ester Simeone, Antonio Sorrentino, Paolo A Ascierto, Silvana Morello
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents. Journal for immunotherapy of cancer 10 (3) (2022)
Nunzia Novizio, Raffaella Belvedere, Elva Morretta, Richard Tomasini, Maria Chiara Monti, Silvana Morello, Antonello Petrella
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity. Cancers 14 (19) (2022)
Roberta Turiello, Mariaelena Capone, Diana Giannarelli, Elva Morretta, Maria Chiara Monti, Gabriele Madonna, Domenico Mallardo, Lucia Festino, Rosa Azzaro, Mitchell P Levesque, Laurence Imhof, Benjamin Weide, Teresa Amaral, Marc Chevrier, Antje Sucker, Piotr Rutkowski, Dirk Schadendorf, Celeste Lebbe, Jason John Luke, Kilian Wistuba-Hamprecht, Reinhard Dummer, Aldo Pinto, Silvana Morello, Paolo A Ascierto
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy. Journal for immunotherapy of cancer 8 (2) (2021)
Silvana Morello, Mariaelena Capone, Claudia Sorrentino, Diana Giannarelli, Gabriele Madonna, Domenico Mallardo, Antonio M Grimaldi, Aldo Pinto, Paolo Antonio Ascierto
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab. Journal of translational medicine 15 (1) (2017)